The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_005629.4(SLC6A8):c.1428C>G (p.Tyr476Ter)

CA415087494

1802549 (ClinVar)

Gene: SLC6A8
Condition: creatine transporter deficiency
Inheritance Mode: X-linked inheritance (dominant (HP:0001423))
UUID: 20afb38a-1bd4-48b1-a126-8ea9ccdadf36
Approved on: 2024-02-22
Published on: 2024-03-29

HGVS expressions

NM_005629.4:c.1428C>G
NM_005629.4(SLC6A8):c.1428C>G (p.Tyr476Ter)
NC_000023.11:g.153694379C>G
CM000685.2:g.153694379C>G
NC_000023.10:g.152959834C>G
CM000685.1:g.152959834C>G
NC_000023.9:g.152613028C>G
NG_012016.1:g.11083C>G
NG_012016.2:g.11083C>G
ENST00000253122.10:c.1428C>G
ENST00000253122.9:c.1428C>G
ENST00000413787.1:c.357C>G
ENST00000430077.6:c.1083C>G
ENST00000442457.1:c.482C>G
ENST00000485324.1:n.1649C>G
NM_001142805.1:c.1398C>G
NM_001142806.1:c.1083C>G
NM_005629.3:c.1428C>G
NM_001142805.2:c.1398C>G

Pathogenic

Met criteria codes 3
PP4 PVS1 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Cerebral Creatine Deficiency Syndromes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for SLC6A8 Version 1.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cerebral Creatine Deficiency Syndromes VCEP
The NM_005629.4: c.1428C>G (p.Tyr476Ter) variant in SLC6A8 is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 10/13, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant has been reported a male with intellectual disability, autistic features, seizures and absent creatine peak on brain MRS (PMID: 29435807) (PP4). The variant is absent in gnomAD v2.1.1. (PM2_Supporting). There is a ClinVar entry for this variant (Variation ID: 1802549). In summary, this variant meets the criteria to be classified as pathogenic for creatine transporter deficiency. SLC6A8-specific criteria applied, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): PVS1, PP4, PM2_Supporting. (Classification approved by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel on February 22, 2024).
Met criteria codes
PP4
At least one male patient with this variant had absent creatine ascertained by brain magnetic resonance spectroscopy; urine creatine/creatinine ratio was not performed (PMID: 29435807).
PVS1
The NM_005629.4: c.1428C>G variant in SLC6A8 is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 10 of 13, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
PM2_Supporting
The variant is absent in gnomAD v2.1.1.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.